enGene Holdings Inc. (ENGN) Stock Forecast

NASDAQ: ENGNAnalyst ratings, price target and estimates.

ENGN analyst forecast

as of October 17, 2026
Analyst consensus
Hold
3.30 / 5 from 10 analysts
Price target
$3.29
average of analyst targets
Upside to target
+96.7%
from the latest close
Next earnings
—
52-week range
$1.44 – $12.17

ENGN analyst ratings

10 analysts
Strong buy
220%
Buy
110%
Hold
660%
Sell
00%
Strong sell
110%

Number of analysts at each rating.

ENGN price target

Price $1.67Target $3.29
52-week low $1.4452-week high $12.17

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

ENGN earnings per share estimates

enGene Holdings Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Jul '26)−$0.43−$0.51−$0.35−$0.57+25.0%8
Next quarter (Jan '27)−$0.34−$0.39−$0.30−$0.44+22.7%3
Current fiscal year (FY2026)−$1.81−$1.89−$1.71−$2.29+21.0%9
Next fiscal year (FY2027)−$1.45−$1.98−$1.03−$1.81+19.6%8

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

ENGN revenue estimates

enGene Holdings Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Jul '26)$0$0$00.0%8
Next quarter (Jan '27)$0$0$00.0%4
Current fiscal year (FY2026)$0$0$00.0%8
Next fiscal year (FY2027)$6.2M$0$14.7M0.0%8

ENGN EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

ENGN revenue: reported and forecast

Reported revenueEstimate (average; low–high)

ENGN EPS estimate revisions

enGene Holdings Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Jul '26)−$0.51−$0.50−$0.43−$0.43−$0.43−15.4%8 up · 0 down
Next quarter (Jan '27)−$0.31−$0.31−$0.34−$0.34−$0.34+10.9%0 up · 3 down
Current fiscal year (FY2026)−$1.73−$1.73−$1.73−$1.83−$1.81+4.5%2 up · 6 down
Next fiscal year (FY2027)−$1.46−$1.40−$1.40−$1.42−$1.45−0.1%3 up · 4 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

ENGN earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; ENGN beat in 6 of 11.

What analysts expect from ENGN

10 analysts cover enGene; their consensus rating is hold (3.30 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.29, 96.7% above the latest close of $1.67. Analysts expect earnings of −$1.81 per share for FY2026, +21.0% from a year earlier. For FY2027 the average estimate is −$1.45 per share on revenue of $6.2 million. enGene beat the EPS estimate in 6 of the last 11 quarters.

Related: ENGN income statement, ENGN key metrics, ENGN chart. See the ENGN stock overview for the latest quote and news.

ENGN forecast FAQ

What is enGene's price target?

The average analyst price target for enGene is $3.29, 96.7% above the latest close of $1.67.

Is enGene a buy, hold or sell?

Of 10 analysts covering enGene, 2 rate it a strong buy, 1 a buy, 6 a hold, 0 a sell and 1 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.

What is enGene's EPS forecast?

Analysts forecast −$1.81 per share for FY2026 (range −$1.89 to −$1.71); for FY2027 the estimate is −$1.45.

Does enGene usually beat earnings estimates?

enGene reported EPS at or above the analyst estimate in 6 of the last 11 quarters.

Biotechnology: forecast